StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Dibutylstannane

HCID 6513
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1002-53-5
Standard-SMILES
CCC[CH2][SnH2][CH2]CCC
InChIKey
WCRDXYSYPCEIAK-UHFFFAOYSA-N
Summenformel
C8H20Sn
Durchschnittliche Molmasse
234,95 g/mol
Monoisotopische Masse
236,058703

Überblick

Dibutylstannane is an organotin compound.

Namen und Bezeichner

Bevorzugter Name
Dibutylstannane
IUPAC
dibutylstannane
Englischer Name
di-n-butyltin
Summenformel
C8H20Sn
Molmasse
234.95

Namen und Synonyme

DibutylstannaneDibutyltin hydrideSnBu2H2CHEBI:23686DTXSID60872503(Sn(Bu)2H2)[Sn(Bu)2H2]RefChem:920060DTXCID90820158621-338-01002-53-5Di-n-butyltin
Weitere Namen anzeigen
Dibutyltin(IV) dihydride
DibutyltinKUM3SW5CW4Stannane, dibutyl-SCHEMBL27446065MFCD00672210SY461382DB-319114NS00112892

Datenbank-Bezeichner

CAS
1002-53-5
PubChem CID
6513
DTXSID
DTXSID60872503
ChEBI
CHEBI:23686
EC Number
621-338-0

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
0
Frei drehbare Bindungen
6
Schwere Atome
9
Formalladung
0
Komplexität
37,8

Physikochemische Eigenschaften

EPA chemische Informationen
Dibutyltin (1002-53-5)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory InformationCouncil Regulation (EEC) No 315/1993
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Toxicological InformationRanking: 403 (total points: 536.28)
Health EffectsBreathing or swallowing, or skin contact with organotins, can interfere with the way the brain and nervous system work, causing death in severe cases. Organic tin compounds may also damage the immune and reproductive system. (L307, L308)
Exposure RoutesOral (L308) ; inhalation (L308) ; dermal (L308)
Toxicity Summary · 1 Eintrag

Organotin compounds produce neurotoxic and immunotoxic effects. Organotins may directly activate glial cells contributing to neuronal cell degeneration by local release of pro-inflammatory cytokines, tumor necrosis factor-_, and/or interleukins. They may also induce apoptosis by direct action on neuronal cells. Organotin compounds stimulate the neuronal release of and/or decrease of neuronal cell uptake of neurotransmitters in brain tissue, including aspartate, GABA, glutamate, norepinephrine, and serotonin. This may be either a contributing factor to or result of the neuronal cell loss. The immunotoxic effects of organotins are characterized by thymic atrophy caused by the suppression of proliferation of immature thymocytes and apoptosis of mature thymocytes. Organotin compounds are believed to exert these effects by suppressing DNA and protein synthesis, inducing the expression of genes involved in apoptosis (such as nur77), and disrupting the regulation of intracellular calcium levels, giving rise to the uncontrolled production of reactive oxygen species, release of cytochrome c to the cytosol, and the proteolytic and nucleolytic cascade of apoptosis. The suppression of proliferation of immature thymocytes further results in the suppression of T-cell-mediated immune responses. Organotins are also endocrine disruptors and are believed to contribute to obesity by inappropriate receptor activation, leading to adipocyte differentiation. Inorganic tin triggers eryptosis, contributing to tin-induced anemia. (L308, A182, A184)

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Though tin metal is very poorly absorbed, tin compounds may be absorbed via oral, inhalation, or dermal routes, with organotin compounds being much more readily absorbed than inorganic tin compounds. Tin may enter the bloodstream and bind to hemoglobin, where it is distributed and accumulates mainly in the kidney, liver, lung, and bone. Organotin compounds may undergo dealkylation, hydroxylation, dearylation, and oxidation catalyzed by cytochrome P-450 enzymes in the liver. The alkyl products of dealkylation are conjugated with glutathione and further metabolized to mercapturic acid derivatives. Tin and its metabolites are excreted mainly in the urine and feces. (L308)

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

Diacetoxybutylzinn

Zugehörige Reaktionen

6
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 729102
HRID 729102als Edukt
Reaktionsgleichung von HRID 1073482
HRID 1073482als Edukt
Reaktionsgleichung von HRID 1073483
HRID 1073483als Edukt
Reaktionsgleichung von HRID 1073485
HRID 1073485als Edukt
Reaktionsgleichung von HRID 1073486
HRID 1073486als Edukt
Reaktionsgleichung von HRID 1091173
HRID 1091173als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Signs and SymptomsInorganic or organic tin compounds placed on the skin or in the eyes can produce skin and eye irritation. (L308)
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

Alarmwort
Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302